2013

Pages

Monday, December 16, 2013

Seven new innovative research projects have been funded through Genome BC’s Strategic Opportunities Fund (SOF). The SOF program, with funding provided by Genome BC and several partners, aims to catalyze new projects and initiatives of strategic importance to BC’s economic sectors. These investments are increasingly recognized for providing foundational research and the projects provide an important basis for future research.

Monday, December 9, 2013

Genome Canada and Génome Québec are pleased to announce UCB Canada Inc.’s contribution to a four-year study aimed at developing a personalized medicine approach to the early diagnosis of various types of epilepsy. The $10.8 million project, “Personalized medicine in the treatment of epilepsy”, forms the Canadian Epilepsy Network (CENet) and is led by Dr. Patrick Cossette at the University of Montreal Hospital Research Centre* (CRCHUM), as well as co-leaders, Dr.

Wednesday, December 4, 2013

Two BC researchers have combined forces to develop  a blood test that will identify patients at high risk for Chronic Obstructive Pulmonary Disease (COPD) lung attacks. This much needed test will help medical professionals provide better treatment and ultimately lead to patients with fewer attacks, and reduced hospitalization and emergency visits.
 

Wednesday, November 27, 2013

One year ago today marked the beginning of “Genome: The Power and the Promise” — a landmark event, presented by the Gairdner Foundation and Genome Canada, to celebrate a decade of progress and discovery in genomics research.

Wednesday, November 13, 2013

ANNOUNCEMENT – The Office of the Privacy Commissioner of Canada (OPC) has issued a call for proposals under its 2014-15 Contributions Program for project proposals aimed at promoting privacy and the protection of personal information in the private sector.

Monday, November 4, 2013

A team of clinical researchers led by CHU de Québec has received CAN$10.5 million from Génome Québec, Genome Canada, CIHR, Genome Alberta and other partners to recruit 5,600 pregnant women in Canada to study the potential of using DNA sequencing alone or in a contingent model with first trimester serum markers as a non-invasive method for detecting birth defects.

Friday, November 1, 2013

From November 1 to December 31, 2013, Statistics Canada is inviting researchers to apply for access to blood, urine and DNA samples from the Canadian Health Measures Survey (CHMS) for use in health studies. The biospecimens are available to any Canadian researcher that completes a review process and would benefit from a national population survey of about 5,600 participants per collection cycle.

Wednesday, October 30, 2013

Genome Canada is delighted to highlight the recent appointment of five new members to its Board of Directors. They include:

Fiona Brinkman, Professor, Molecular Biology and Biochemistry at Simon Fraser University

Jay Ingram, Broadcaster and Science Writer

Kim McConnell, Founder and former CEO, AdFarm

Moura Quayle, Professor, Strategic Design, Sauder School of Business, University of British Columbia

Donald Ziraldo, Co-founder, Inniskillin Wines

Friday, October 25, 2013

The Structural Genomics Consortium (SGC) announced today that Janssen Pharmaceuticals NV has joined its group to partner in the investigation of epigenetics-based drug research, a new and burgeoning field in the development of future medicines.

Monday, October 21, 2013

Dr. Fabrice Brunet, Chief Executive Officer at Sainte-Justine UHC, and Marc LePage, President and CEO of Génome Québec, are extremely proud to announce the launch of Canada’s first integrated clinical genomic centre in pediatrics, an initiative currently at the forefront of global efforts in this area. "We are honoured to have the opportunity to make this partnership a reality in the presence of the Québec Premier, Pauline Marois, and Dr.

Pages